CUSIP 56565P103COMMPLTQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
74 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Novo Holdings A/S | 3.69M | $64.76M | +3.69M | New |
| 2 | Fcpm III Services B.V. | 3.23M | $56.67M | +3.23M | New |
| 3 | Goldman Sachs Group Inc | 1.94M | $34.03M | +1.94M | New |
| 4 | Blackrock, Inc. | 1.10M | $19.24M |
| New |
| 5 | Nan Fung Group Holdings Ltd | 971.3K | $17.06M | +971.3K | New |
| 6 | 5am Venture Management, LLC | 950.0K | $16.69M | +950.0K | New |
| 7 | Sanofi | 912.0K | $16.02M | +912.0K | New |
| 8 | Vanguard Group Inc | 869.7K | $15.28M | +869.7K | New |
| 9 | Pivotal Bioventure Partners Investment Advisor LLC | 611.4K | $10.74M | +611.4K | New |
| 10 | Perceptive Advisors LLC | 550.0K | $9.66M | +550.0K | New |
See every fund holding Maplight Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders